Crispr Therapeutics AG (CRSP) valuation · rev $3.5M
Crispr Therapeutics AG (CRSP) rev $3.5M.
| Metric | Value |
|---|---|
| Market cap | $5.42B |
| Revenue | $3.5M |
| P/S | 1544.4 |
CRSP valuation FAQ
What is CRSP's market cap?
Crispr Therapeutics AG (CRSP) market cap is $5.42B on the latest cached fundamentals snapshot.
What is CRSP's latest revenue?
Latest cached Crispr Therapeutics AG (CRSP) revenue was $3.5M. Statements: https://lician.com/financials/crsp
What is CRSP's price-to-sales ratio?
Crispr Therapeutics AG (CRSP) price-to-sales (P/S) is 1544.4, cached market cap $5.42B divided by revenue $3.5M.
How many CRSP valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Crispr Therapeutics AG (CRSP): Market cap, Revenue, and P/S.
Where is CRSP valuation listed?
Cached valuation multiples for Crispr Therapeutics AG (CRSP) are listed at https://lician.com/valuation/crsp.
Not investment advice. Figures as filed or reported, not a live feed.